NOX
Noxopharm
Pharmaceuticals, Biotechnology & Life Sciences
Noxopharm Limited (ASX:NOX) is an Australian clinical-stage drug development company focused on the treatment of cancer and cytokine release syndrome (septic shock).
Shorted
short percentage0.00%
reported shorts11.7K
shares on issue292.238M
About
website
industry
address
Key Metrics
market cap
$21.92Meps$-0.02
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Short Position Trends
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns